文献速递脑血管病

心房病变与缺血性卒中风险:心血管健康研究

Atrial Cardiopathy and the Risk of Ischemic Stroke in the CHS (Cardiovascular Health Study).
PubMed 文献 · Stroke · 2018-03-13

心血管健康研究前瞻性纳入≥65岁社区成人,排除基线卒中或房颤者,分析心房病变标志物与新发缺血性卒中的关联。中位随访12.9年,3723名参与者中585人(15.7%)发生缺血性卒中;校正后P波终末力、NT-proBNP及新发房颤与卒中显著相关,左房内径无显著关联。

要点

  • P波终末力每增加1000 μV*ms,缺血性卒中风险HR 1.04(95%CI 1.001-1.08)。
  • NT-proBNP每翻倍,缺血性卒中风险HR 1.09(95%CI 1.03-1.16)。
  • 新发房颤与缺血性卒中风险HR 2.04(95%CI 1.67-2.48)相关。

核心结论

  • 除临床明显的房颤外,其他心房异常基质的证据与后续缺血性卒中相关,符合左心房血栓栓塞可发生于多种心房疾病表现的假说。

研究设计与样本

  • 心血管健康研究前瞻性纳入≥65岁社区居住成人,排除基线卒中或房颤者,最终分析3723名具有全部心房病变标志物数据的参与者。

主要发现

  • 中位随访12.9年期间,585名参与者(15.7%)发生新发缺血性卒中。
  • 在同时包含4种心房病变标志物的Cox模型中,P波终末力每增加1000 μV*ms与卒中显著相关(HR 1.04;95%CI 1.001-1.08)。
  • log转换的NT-proBNP每翻倍与卒中显著相关(HR 1.09;95%CI 1.03-1.16)。
  • 新发房颤与卒中显著相关(HR 2.04;95%CI 1.67-2.48)。
  • 左房内径每增加1 cm与卒中无显著关联(HR 0.96;95%CI 0.84-1.10)。

关键数值与推荐

  • P波终末力(ECG导联V1)每1000 μV*ms的HR为1.04(95%CI 1.001-1.08)。
  • NT-proBNP每翻倍的HR为1.09(95%CI 1.03-1.16)。
  • 新发房颤的HR为2.04(95%CI 1.67-2.48)。
  • 左房内径每cm的HR为0.96(95%CI 0.84-1.10)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Emerging evidence suggests that an underlying atrial cardiopathy may result in thromboembolism before atrial fibrillation (AF) develops. We examined the association between various markers of atrial cardiopathy and the risk of ischemic stroke. METHODS: The CHS (Cardiovascular Health Study) prospectively enrolled community-dwelling adults ≥65 years of age. For this study, we excluded participants diagnosed with stroke or AF before baseline. Exposures were several markers of atrial cardiopathy: baseline P-wave terminal force in ECG lead V1, left atrial dimension on echocardiogram, and N terminal pro B type natriuretic peptide (NT-proBNP), as well as incident AF. Incident AF was ascertained from 12-lead electrocardiograms at annual study visits for the first decade after study enrollment and from inpatient and outpatient Medicare data throughout follow-up. The primary outcome was incident ischemic stroke. We used Cox proportional hazards models that included all 4 atrial cardiopathy markers along with adjustment for demographic characteristics and established vascular risk factors. RESULTS: Among 3723 participants who were free of stroke and AF at baseline and who had data on all atrial cardiopathy markers, 585 participants (15.7%) experienced an incident ischemic stroke during a median 12.9 years of follow-up. When all atrial cardiopathy markers were combined in 1 Cox model, we found significant associations with stroke for P-wave terminal force in ECG lead V1 (hazard ratio per 1000 μV*ms 1.04; 95% confidence interval, 1.001-1.08), log-transformed NT-proBNP (hazard ratio per doubling of NT-proBNP, 1.09; 95% confidence interval, 1.03-1.16), and incident AF (hazard ratio, 2.04; 95% confidence interval, 1.67-2.48) but not left atrial dimension (hazard ratio per cm, 0.96; 95% confidence interval, 0.84-1.10). CONCLUSIONS: In addition to clinically apparent AF, other evidence of abnormal atrial substrate is associated with subsequent ischemic stroke. This finding is consistent with the hypothesis that thromboembolism from the left atrium may occur in the setting of several different manifestations of atrial disease.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Kamel H, Bartz TM, Elkind MSV, et al. Atrial Cardiopathy and the Risk of Ischemic Stroke in the CHS (Cardiovascular Health Study). Stroke. 2018. PMID: 29535268. doi:10.1161/STROKEAHA.117.020059

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。